Literature DB >> 29610128

Renin-Angiotensin-Aldosterone System Inhibitors for Right Ventricular Dysfunction in Tetralogy of Fallot: Quo Vadis?

Sushma Reddy1, Daniel Bernstein1, Jane W Newburger2,3.   

Abstract

Entities:  

Keywords:  Editorials; heart defects, congenital; heart diseases; heart failure; losartan; survival; tetralogy of Fallot

Mesh：

Substances：

Year:  2018        PMID： 29610128      PMCID： PMC5886745          DOI： 10.1161/CIRCULATIONAHA.117.032285

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  14 in total

1.  Therapeutic options for systemic right ventricular failure.

Authors:  P Szymañski; A Klisiewicz; P Hoffman
Journal:  Heart       Date:  2009-12       Impact factor: 5.994

Review 2.  Right versus left ventricular failure: differences, similarities, and interactions.

Authors:  Mark K Friedberg; Andrew N Redington
Journal:  Circulation       Date:  2014-03-04       Impact factor: 29.690

3.  Effect of Losartan on Right Ventricular Dysfunction: Results From the Double-Blind, Randomized REDEFINE Trial (Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-Angiotensin-Aldosterone System) in Adults With Repaired Tetralogy of Fallot.

Authors:  Jouke P Bokma; Michiel M Winter; Arie P van Dijk; Hubert W Vliegen; Joost P van Melle; Folkert J Meijboom; Martijn C Post; Jacqueline K Berbee; S Matthijs Boekholdt; Maarten Groenink; Aeilko H Zwinderman; Barbara J M Mulder; Berto J Bouma
Journal:  Circulation       Date:  2017-12-08       Impact factor: 29.690

4.  A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot.

Authors:  Jouke P Bokma; Tal Geva; Lynn A Sleeper; Sonya V Babu Narayan; Rachel Wald; Kelsey Hickey; Katrijn Jansen; Rebecca Wassall; Minmin Lu; Michael A Gatzoulis; Barbara Jm Mulder; Anne Marie Valente
Journal:  Heart       Date:  2017-11-01       Impact factor: 5.994

5.  Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery.

Authors:  I S Anand; Y Chandrashekhar; R Ferrari; R Sarma; R Guleria; S K Jindal; P L Wahi; P A Poole-Wilson; P Harris
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

6.  Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform.

Authors:  Richard P Kondo; Dorothy A Dederko; Christine Teutsch; Jacqueline Chrast; Daniele Catalucci; Kenneth R Chien; Wayne R Giles
Journal:  J Physiol       Date:  2005-12-15       Impact factor: 5.182

Review 7.  The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series).

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

Review 8.  Molecular Mechanisms of Right Ventricular Failure.

Authors:  Sushma Reddy; Daniel Bernstein
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

9.  Adverse biventricular remodeling in isolated right ventricular hypertension is mediated by increased transforming growth factor-β1 signaling and is abrogated by angiotensin receptor blockade.

Authors:  Mark K Friedberg; Mi-Young Cho; Jing Li; Renato S Assad; Mei Sun; Sagar Rohailla; Osami Honjo; Christian Apitz; Andrew N Redington
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

10.  Carvedilol for children and adolescents with heart failure: a randomized controlled trial.

Authors:  Robert E Shaddy; Mark M Boucek; Daphne T Hsu; Robert J Boucek; Charles E Canter; Lynn Mahony; Robert D Ross; Elfriede Pahl; Elizabeth D Blume; Debra A Dodd; David N Rosenthal; Jeri Burr; Bernie LaSalle; Richard Holubkov; Mary Ann Lukas; Lloyd Y Tani
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272
View more
  2 in total

1.  4HNE Impairs Myocardial Bioenergetics in Congenital Heart Disease-Induced Right Ventricular Failure.

Authors:  HyunTae V Hwang; Nefthi Sandeep; Sharon L Paige; Sara Ranjbarvaziri; Dong-Qing Hu; Mingming Zhao; Ingrid S Lan; Michael Coronado; Kristina B Kooiker; Sean M Wu; Giovanni Fajardo; Daniel Bernstein; Sushma Reddy
Journal:  Circulation       Date:  2020-08-18       Impact factor: 29.690

2.  Lack of Contribution of p66shc to Pressure Overload-Induced Right Heart Hypertrophy.

Authors:  Christine Hirschhäuser; Akylbek Sydykov; Annemarie Wolf; Azadeh Esfandiary; Julia Bornbaum; Hanna Sarah Kutsche; Kerstin Boengler; Natascha Sommer; Rolf Schreckenberg; Klaus-Dieter Schlüter; Norbert Weissmann; Ralph Schermuly; Rainer Schulz
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.